Clinical Trial Update: Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure [Phase 3]

View source ↗

Summary

This document notes the completion status of a Phase 3 trial evaluating an oral fixed-dose combination of glimepiride, vildagliptin, and metformin in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Galvus (vildagliptin)
• Glucophage (metformin)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED